Kinetics Medical Fund Class A (KRXAX)

23.34
Net Asset Value
+0.34%
1 Day
-4.07%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
5.75
Sales Expenses
2.33%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio- a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks- convertible securities- warrants- and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research- pharmaceutical and medical technology industries and related technology industries- with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Performance

1 month-1.06% 3 years-3.06%
3 months-8.76% 5 years+7.15%
1 year+3.60% Since inception+5.68%
Data through --

Peer Comparisonvs. Health

 KRXAXCategory
Performance 5-yr return+7.15%+14.29%
Expense ratio2.33%1.30%
Risk 5 year sharpe ratio0.650.92
Net assets$18.4M$3.0B
Average market cap$68.0B$10.0B
Average P/E24.022.2
Portfolio turnover0%0%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyKinetics
Fund manager & tenureBruce Abel / 18 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock69.73%
International stock27.02%
Cash3.20%
Fixed income0.05%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.65%
Industrial materials 4.23%
Business service 1.12%
Telecommunication 0.01%
Consumer goods 0.00%
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co8.19%
PFE Pfizer7.95%
BMY Bristol-Myers Squibb7.51%
JNJ Johnson & Johnson6.42%
ABBV AbbVie6.42%
ALKS Alkermes Plc6.15%
BIIB Biogen6.10%
NVS Novartis6.00%
SNY Sanofi5.49%
AZN AstraZeneca4.96%